thiazoles has been researched along with Benign Mastocytoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, K; Jin, Y; Pan, J; Shen, M; Wang, D | 1 |
| Dobson, JM; Foale, RD; Miller, RL; Van Lelyveld, S; Warland, J | 1 |
| Devine, L; Polzin, DJ | 1 |
| Gleixner, KV; Hadzijusufovic, E; Mirkina, I; Peter, B; Pickl, WF; Schuch, K; Thaiwong, T; Valent, P; Willmann, M; Yuzbasiyan-Gurkan, V | 1 |
| Bondzio, A; Einspanier, R; Gruber, AD; Hummel, M; Klopfleisch, R; Lenze, D; Meyer, A; Schlieben, P; Weise, C | 1 |
| Hwu, P; Liu, C; Liu, Y; Lizée, G; Overwijk, WW; Peng, W; Woodman, SE; Yang, Y | 1 |
| Caux, C; Marabelle, A | 1 |
7 other study(ies) available for thiazoles and Benign Mastocytoma
| Article | Year |
|---|---|
Novel thiazole amine class tyrosine kinase inhibitors induce apoptosis in human mast cells expressing D816V KIT mutation.
Topics: Amines; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Genotype; Humans; Male; Mast Cells; Mastocytoma; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; Mutation; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; RNA Interference; Signal Transduction; Thiazoles; Time Factors; Transfection; Xenograft Model Antitumor Assays | 2014 |
A retrospective review of treatment and response of high-risk mast cell tumours in dogs.
Topics: Animals; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Mastocytoma; Neoplasm Grading; Piperidines; Protein Kinase Inhibitors; Pyridines; Retrospective Studies; Risk Factors; Survival Analysis; Thiazoles; Treatment Outcome | 2016 |
Presumed masitinib-induced nephrotic syndrome and azotemia in a dog.
Topics: Animals; Antineoplastic Agents; Azotemia; Benzamides; Dog Diseases; Dogs; Female; Mastocytoma; Nephrotic Syndrome; Piperidines; Protein-Tyrosine Kinases; Pyridines; Thiazoles | 2016 |
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cats; Cell Line, Tumor; Cell Proliferation; Dasatinib; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Histamine H1 Antagonists, Non-Sedating; Humans; Inhibitory Concentration 50; Loratadine; Mastocytoma; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Pyrimidines; Staurosporine; Terfenadine; Thiazoles; Tumor Cells, Cultured | 2010 |
Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes.
Topics: Animals; Benzamides; Cell Death; Cell Line, Tumor; Cell Proliferation; Dogs; Gene Expression Regulation, Neoplastic; Mastocytoma; Piperidines; Proto-Oncogene Proteins c-kit; Pyridines; RNA, Messenger; Signal Transduction; Thiazoles; Transcriptome; Up-Regulation | 2012 |
Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.
Topics: Animals; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemokines; Dasatinib; Drug Administration Schedule; Drug Synergism; Flow Cytometry; Gene Expression Regulation, Neoplastic; Interferon-gamma; Mastocytoma; Mice; Mice, Inbred DBA; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, OX40; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; T-Lymphocytes, Regulatory; Thiazoles; Tumor Burden; Tumor Microenvironment | 2012 |
Immunobiology. Combined targeted and immunotherapy: the future of personalized medicine.
Topics: Animals; Antibodies; Dasatinib; Mastocytoma; Pyrimidines; T-Lymphocytes; Thiazoles | 2012 |